CN111227229A - Plant source nutrition powder and preparation method and edible method thereof - Google Patents
Plant source nutrition powder and preparation method and edible method thereof Download PDFInfo
- Publication number
- CN111227229A CN111227229A CN202010029153.4A CN202010029153A CN111227229A CN 111227229 A CN111227229 A CN 111227229A CN 202010029153 A CN202010029153 A CN 202010029153A CN 111227229 A CN111227229 A CN 111227229A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- plant source
- nutrition powder
- source nutrition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 87
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 70
- 230000035764 nutrition Effects 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims abstract description 64
- 239000002994 raw material Substances 0.000 claims abstract description 31
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 244000144725 Amygdalus communis Species 0.000 claims abstract description 7
- 244000075850 Avena orientalis Species 0.000 claims abstract description 7
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 7
- 244000060011 Cocos nucifera Species 0.000 claims abstract description 7
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 7
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 7
- 244000068988 Glycine max Species 0.000 claims abstract description 7
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 7
- 244000197580 Poria cocos Species 0.000 claims abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 7
- 235000020224 almond Nutrition 0.000 claims abstract description 7
- 241000758791 Juglandaceae Species 0.000 claims abstract description 5
- 241000133134 Saussurea Species 0.000 claims abstract description 5
- 244000000231 Sesamum indicum Species 0.000 claims abstract description 5
- 235000003434 Sesamum indicum Nutrition 0.000 claims abstract description 5
- 235000020234 walnut Nutrition 0.000 claims abstract description 5
- 238000004880 explosion Methods 0.000 claims description 18
- 235000013336 milk Nutrition 0.000 claims description 11
- 239000008267 milk Substances 0.000 claims description 11
- 210000004080 milk Anatomy 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 230000001863 plant nutrition Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 40
- 239000008280 blood Substances 0.000 abstract description 40
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 12
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000001603 reducing effect Effects 0.000 abstract description 4
- 210000004204 blood vessel Anatomy 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 238000000151 deposition Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 38
- 241000699670 Mus sp. Species 0.000 description 27
- 239000000047 product Substances 0.000 description 25
- 241000700159 Rattus Species 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 238000010171 animal model Methods 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 230000035488 systolic blood pressure Effects 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 230000035487 diastolic blood pressure Effects 0.000 description 6
- 239000002960 lipid emulsion Substances 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000020828 fasting Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000011344 liquid material Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 230000003044 adaptive effect Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000020245 plant milk Nutrition 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000011552 rat model Methods 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 235000020927 12-h fasting Nutrition 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 101800000068 Antioxidant peptide Proteins 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000035762 Disorder of lipid metabolism Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- -1 antiseptics Substances 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 235000014590 basal diet Nutrition 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000364 effect on atherosclerosis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/10—General methods of cooking foods, e.g. by roasting or frying
- A23L5/13—General methods of cooking foods, e.g. by roasting or frying using water or steam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Agronomy & Crop Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a plant source nutrition powder and a preparation method and an edible method thereof. A plant source nutrition powder comprises the following raw materials in parts by weight: 3-10 parts of soybeans, 3-8 parts of Chinese yam, 2-7 parts of saussurea involucrate seeds, 8-15 parts of oats, 5-10 parts of almonds, 0-1.5 parts of white sesame seeds, 0-1.5 parts of walnuts, 0-20 parts of coix seeds, 0-20 parts of poria cocos and 50-80 parts of coconut powder. The raw material combination can provide balanced and comprehensive nutrition level for users, and is beneficial to converting healthy life style, thereby regulating and reducing the contents of blood sugar, blood fat and serum cholesterol, preventing the cholesterol from depositing on the inner wall of blood vessels, removing the deposits, reducing the blood viscosity and promoting the blood circulation.
Description
Technical Field
The invention belongs to the field of functional foods, and particularly relates to plant source nutrition powder and a preparation method and an edible method thereof.
Background
At present, the dietary structure of people is greatly changed, sub-health people are increased year by year, and particularly, three-high patients are remarkably increased due to the fact that the life rhythm of developed regions is accelerated and the working pressure is increased. More and more people pay attention to health care and pay attention to diet, so that the research on functional ingredients of food and the development of functional food become hot spots of food research at home and abroad aiming at the specific requirements of specific people, and the method has wide market prospect.
Disclosure of Invention
The invention aims to provide plant source nutrition powder, a preparation method and an eating method thereof, so as to improve the blood pressure, blood fat and blood sugar levels of people eating the powder through functional food.
According to one aspect of the invention, the plant source nutrition powder comprises the following raw materials in parts by weight: 3-10 parts of soybeans, 3-8 parts of Chinese yam, 2-7 parts of saussurea involucrate seeds, 8-15 parts of oats, 5-10 parts of almonds, 0-1.5 parts of white sesame seeds, 0-1.5 parts of walnuts, 0-20 parts of coix seeds, 0-20 parts of poria cocos and 50-80 parts of coconut powder.
Preferably, the raw materials comprise, by mass: 3.5-6 parts of soybeans, 4-7 parts of Chinese yam, 2.5-5 parts of saussurea involucrate seeds, 10-15 parts of oats, 6-9 parts of almonds, 1-8 parts of coix seeds, 1-5 parts of poria cocos and 60-70 parts of coconut powder.
Preferably, the raw materials comprise, by mass: 5 parts of soybeans, 5 parts of Chinese yam, 4 parts of snow lotus seeds, 12 parts of oat, 8 parts of almonds, 1 part of white sesame seeds, 1 part of walnuts, 3 parts of coix seeds, 2 parts of poria cocos and 64 parts of coconut powder.
Preferably, the raw materials also comprise 0.5 to 3 parts of trehalose by weight.
Preferably, the raw material comprises 1 part of trehalose by mass.
According to another aspect of the present invention, there is provided a method for preparing the plant source nutrition powder, which comprises the following steps: steam explosion pretreatment: performing steam explosion pretreatment on the raw materials by adopting a steam explosion method to obtain a steam explosion product; and (3) drying: drying the steam explosion product; a material mixing step: and uniformly mixing the dried materials to obtain a finished product.
Preferably, the specific parameters of the steam explosion pretreatment step are set as follows: setting the steam explosion pressure at 0.5-3 MPa, and maintaining for 15-45 s.
According to another aspect of the present invention, there is provided a method for eating the plant source nutrition powder, which is characterized in that: according to the plant source nutrition powder: milk 1: 3-10, and adding the plant source nutrition powder into the milk for administration.
The raw materials are combined to form the raw material components of the plant source nutrition powder, and the raw material combination can provide balanced and comprehensive nutrition level for eaters, particularly, various active substances such as lecithin, isoflavone, Chinese yam mucilage, β -glucan, antioxidant peptide, ACE (angiotensin converting enzyme) inhibitory peptide, platelet aggregation activity inhibitory peptide, antihypertensive peptide, lactoferrin, immunoglobulin, metallothionein, brown pigment, enzyme protein, collagen, alcohol soluble protein and soybean protein isolate contained in the raw materials can be converted into a healthy life style through various in vivo action mechanisms, so that the blood sugar, blood fat and serum cholesterol content can be adjusted, the deposition of cholesterol on the inner wall of a blood vessel is prevented, the viscosity of the cholesterol is eliminated, and the blood circulation function of the blood is reduced.
The method provided by the invention is adopted to process the raw materials, so that the effective active ingredients in the raw materials can be effectively released, or the nutrient substances in the raw materials are converted to a form more beneficial to the absorption of a human body, and the finally prepared plant source nutrient powder can help to regulate the blood sugar, the blood fat and the blood pressure of a user, is beneficial to keeping the blood sugar, the blood fat and the blood pressure of the user in a normal level range, and promotes the cardiovascular and cerebrovascular of the user to be in a healthy state.
The plant source nutrition powder provided by the invention does not contain any additives such as hormone, antibiotics, preservatives and the like, has fragrant and smooth taste, does not cause excessive internal heat, can be taken by being mixed with milk or honey, and can also be used as a health maintenance meal replacement bag. The milk is a nutrient substance containing rich nutrient components, however, in real life, many children and children can cause the phenomena of constipation, hemorrhoids, pharyngitis, fever and the like caused by drinking the milk, the milk is added into the plant source nutrient powder provided by the invention to prepare the plant milk, and the plant milk is used as a daily diet regulating food, so that the excessive ingestion of fish, meat, eggs and milk of a user can be effectively relieved, and various chronic diseases caused by the excessive fish, meat, eggs and milk can be effectively reduced. The proper use of the 'plant milk' can effectively reduce the intake of chemical substances such as food additives, antiseptics, antibiotics, hormones and the like in a human body, reduce the dependence on fish, egg and milk, reduce the adverse effect of regulating blood fat, blood sugar and cholesterol on the human body, effectively prevent various acute and chronic diseases, can shape and beautify the skin, and supplement various trace elements, plant protein, amino acid, fatty acid and other nutrient substances required by the human body, and is a faithful partner for the health of the whole people in modern elegant life.
Drawings
FIG. 1 is a graph showing the change in SBP of the experimental mouse of example 3;
FIG. 2 is a graph showing DBP changes in the experimental mice of example 3.
Detailed Description
In order to make the technical solutions of the present invention better understood by those skilled in the art, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Example 1
In this example, 5 plant source nutrition powders were prepared by weighing the required raw materials according to the raw material amounts listed in table 1.
TABLE 1 raw Material composition of the plant-derived nutrient powder prepared in example 1
The preparation method of the plant source nutrition powder A, the plant source nutrition powder B, the plant source nutrition powder C and the plant source nutrition powder D comprises the following steps:
weighing the required raw materials according to the amount shown in the table 1, mixing the raw materials, cutting into powder, further uniformly mixing the crushed raw materials, and sieving by a 40-mesh sieve to obtain a finished product.
The main equipment required for preparing the plant source nutrition powder E comprises the following components: QBS-80 supersonic ejection type air blasting machine (Heliandao biological energy Co., Ltd.), experimental spray dryer SP-1500 (Shanghai Shunji). The preparation method of the plant source nutrition powder E comprises the following steps:
weighing the required raw materials according to the amount shown in table 1, mixing the raw materials, cutting the raw materials into pieces, putting the crushed raw materials into a reaction chamber of a steam explosion machine, setting the steam explosion pressure to be 2MPa and maintaining the pressure for 30 seconds to obtain a steam explosion product, drying the steam explosion product by using a spray dryer to obtain a semi-finished product, cutting the semi-finished product into powder, further uniformly mixing the powder, and sieving the powder by using a 40-mesh sieve to obtain the plant source nutrition powder E.
Example 2
Blood lipid lowering experiment
1. Experimental construction mode
Hyperlipidemia is a common disorder of lipid metabolism, and can be promoted by high-fat and high-cholesterol diet, and hyperlipidemia is a main cause of atherosclerosis. In this example, an experimental group was set up using 5 plant-derived nutritional powders prepared in example 1 as reference products, a control group was set up, and a hyperlipidemic rat model was constructed using high fat emulsion gavage SD (Sprague-dawley, SD) rats. The lipid metabolism of rats is observed, and serum TG, TC, LDL-C and HDL-C are detected simultaneously, so as to preliminarily discuss the protective effect of each reference product on blood vessels.
2. Main experimental materials
Lard, commercially available; cholesterol, shanghai xin tide biotechnology, ltd; propylthiouracil, Shanghai Korea Daihui pharmaceutical Co., Ltd; sodium cholate, shanghai source leaf biotechnology limited; simvastatin, a limited Tianfang pharmaceutical industry company; four blood lipid detection kits (TC/TG/LDL-C/HDL-C) and NOS detection kits; preparing a high-fat emulsion (Liulijuan, Zhouchui. an experimental study for establishing a rat model of hyperlipidemia and hypertension [ J ]. J. Med. in lake south, 2010,26(6): 111-112.); the other reagents are analytically pure.
3. Main equipment
Bio Tek EonTMMicroplate spectrophotometer, Biotek Instruments, Ins, usa;
ALLEGRAX-12R Universal desk top refrigerated centrifuge, Beckman Coulter, USA;
FRESCO21 Mini desk refrigerated centrifuge, Theromo Scientific, USA;
free Zone 12plus vacuum freeze dryer, Labconco, usa;
SJM-DGN-02 multifunctional membrane separation equipment, Hefeijie Membrane engineering, LLC.
4. Laboratory animal management
Experimental animals SPF grade male SD rats, 6 weeks old, 120 + -20 g in body weight. Raising temperature: 25 ± 2 ℃, humidity: 40-70%, 12h light and shade alternate illumination, free diet and water intake. All experiments were reviewed and approved by the ethics committee for laboratory animals and performed according to the operating guidelines.
After 7 days of adaptive feeding, the mice were divided into a blank group and a high fat emulsion group, the blank group was re-fed with physiological saline every 1mL/100g body per day, and the high fat emulsion group was re-fed with high fat emulsion every 1mL/100g body for 1 time/d for 60 days, while normally supplying drinking water and basal diet. After the last 1 gastric lavage, the animals in each group were fasted for 12h without water supply. The infraorbital venous plexus was bled, serum was isolated, and serum TC, LDL-C and HDL-C levels were determined to see if the model was successful. And randomly selecting 48 high-fat model groups of experimental mice successfully modeled, randomly dividing the experimental mice into 6 groups, and respectively numbering the groups into an experiment I group, an experiment II group, an experiment III group, an experiment IV group, an experiment V group and a control II group, wherein each group comprises 8 mice, and each experimental mouse is a duplicate. From the blank group, 8 mice were randomly selected as control group I mice, one replicate for each mouse.
5. Preparation of feeding liquid
The 5 plant source nutrition powders prepared in the example 1 are used as reference products, each group of reference products (powder) are weighed according to the dosage of 105mg/kg, the reference products are mixed with boiled water to prepare feeding liquid, the feeding liquid is used for feeding experimental mice of an experimental group, and the experimental mice of a control group I and a control group II are fed with normal saline. Groups of mice and corresponding gavage liquid are shown in table 1.
TABLE 1 grouping of blood fat-reducing experimental animals and ingredients of gastric lavage liquid
Group of | Gastric lavage liquid material | Group of | Gastric lavage liquid material |
Experiment I group | Plant source nutrition powder A | Control group I | Physiological saline |
Experiment II group | Plant source nutrition powder B | Control group II | Physiological saline |
Experiment group III | Plant source nutrition powder C | ||
Experimental group IV | Plant source nutrition powder D | ||
Experiment group V | Plant source nutrition powder E |
6. Index acquisition mode
Serum preparation: after the last gastric lavage of each group of animals, fasting for 12h without water prohibition, carrying out abdominal anesthesia by using 10% chloral hydrate according to 400mg/kg of body weight, collecting about 5mL of whole blood from abdominal aorta, standing at room temperature, naturally coagulating the blood, centrifuging (3500rpm, 10min, 4 ℃), taking yellow transparent supernatant fluid as serum, and subpackaging the serum into a plurality of 1.5m L Eppendorf (EP) tubes for later use at-20 ℃. The TC, LDL-C and HDL-C of serum are measured by using a microplate spectrophotometer and a scientific research kit, and the specific operation method refers to the kit specification.
With reference to the method provided in the prior art (Feng L J, Yu C H, Ying K J, et al. Hyperpolipidemic and systemic effects of total flavanoids of Perilla fractions with induced by high-fat stream [ J ]. Food research International,2011,44(1):404- > 409 ]), the Atherosclerosis Index (AI) is calculated according to the following formula:
7. results of the experiment
Hyperlipidemia is characterized by abnormal lipid levels caused by elevated TC and LDL-C levels and lowered HDL-C levels in the blood. Compared with the control group I, the TC and LDL-C levels of the experimental mice of the control group II and the experimental groups I-V are obviously higher, while the HDL-C level is obviously lower before the test products are fed, so that the successful modeling of the experimental mice of the high-fat emulsion group is proved. Table 2 shows the change of serum index before and after the experiment of feeding the test products. As can be seen from Table 2, the serum index levels of the groups I-V of the test products fed by the feeding were improved, wherein the serum index of the group IV of the test products was closest to the normal level (group II of the control products), and the serum index of the group II of the control products was further developed in the direction deviating from the normal level. The AI of the experimental groups I-V is obviously reduced, and the plant source nutrition powder prepared in the example 1 can improve the adverse condition of atherosclerosis of experimental mice and has a certain prevention effect on atherosclerosis.
According to the experimental results of this example, 5 plant-derived nutrition powders prepared in example 1 can effectively reduce the blood lipid level of the experimental mouse, and the magnitude sequence of the blood lipid reducing effect is as follows: the plant source nutrition powder E, the plant source nutrition powder B, the plant source nutrition powder D, the plant source nutrition powder C and the plant source nutrition powder A are all mixed.
TABLE 2 serum indices before (day 0) and after (day 30) the feeding experiment
(unit: mmol/L)
Example 3
Blood pressure lowering experiment
1. Animal management mode
Experiments were performed using 14-17 week old male SHR rats weighing 280 ± 20g, feeding temperature: 25 ± 2 ℃, humidity: 40-70%, 12h light and shade alternate illumination, and free intake and drinking. All experiments were approved and approved by the laboratory animal ethics committee and performed according to the operating guidelines.
2. Principal devices or materials
NO rat Elisa kit, tokyo senega biotechnology ltd;
ALC-NIBP non-invasive blood pressure measurement and analysis system, Shanghai Oercote Biotech limited;
bio Tek Eon TM microplate spectrophotometer, Biotek Instruments, Ins, USA;
tissue grinder with medium and high flux of Tissue Lyser II, QIAGEN, Germany;
ALLEGRAX-12R Universal desk top refrigerated centrifuge, Beckman Coulter, USA;
FRESCO21 Mini desk refrigerated centrifuge, Theromo Scientific, USA;
free Zone 12plus vacuum freeze dryer, Labconco, usa.
3. Preparation of feeding liquid
The 5 plant-derived nutrition powders prepared in example 1 were used as reference products, each group of reference products (powder) was weighed according to a dosage of 105mg/kg, and the reference products were mixed with boiled water to prepare feeding solutions, and the feeding solutions were fed to the experimental rats of the experimental group, and the experimental rats of the control group were fed with physiological saline. Groups of mice and corresponding gavage liquid are shown in table 3.
TABLE 3 grouping of hypotensive experimental animals and ingredients of gavage liquid
Group of | Gastric lavage liquid material | Group of | Gastric lavage liquid material |
Experiment I group | Plant source nutrition powder A | Experimental group IV | Plant source nutrition powder D |
Experiment II group | Plant source nutrition powder B | Experiment group V | Plant source nutrition powder E |
Experiment group III | Plant source nutrition powder C | Control group | Physiological saline |
4. Data acquisition mode
A42-day Blood Pressure lowering effect test was conducted using a mouse having a Systolic Blood Pressure (SBP) of 170mm Hg or more. After 10 days of adaptive training in SHR, gavage experiments were performed and the animal groups and doses are shown in Table 3. The gavage time was continued for 6 weeks, SBP and Diastolic Blood Pressure (DBP) were measured once a week, and the effect of each test substance on the Blood Pressure of SHR rats was observed.
5. Results of the experiment
The test results of SBP and DBP are shown in FIG. 1 and FIG. 2, respectively, and it can be seen from the figure that SBP and DBP of the control group always maintain higher levels, relatively speaking, SBP and DBP levels corresponding to the experimental groups I-V are all in a descending trend, and the magnitude order of the pressure-reducing effect is as follows: the plant source nutrition powder A, the plant source nutrition powder E, the plant source nutrition powder B, the plant source nutrition powder D and the plant source nutrition powder C are sequentially mixed. Compared with the experimental mouse fed with the plant source nutrition powder A, the experimental mouse fed with the plant source nutrition powder B, the plant source nutrition powder C, the plant source nutrition powder D and the plant source nutrition powder E respectively has a relatively stable trend of decreasing the blood sugar level, so that the experimental mouse is more beneficial to the adaptation of a body, and when the experiment is carried out for 42 days, the blood pressure of the experimental mouse fed with the plant source nutrition powder E is closest to a normal value.
Example 4
Blood sugar lowering experiment
1. Experimental construction mode
Experiments were performed using 14-17 week old male SHR rats weighing 280 ± 20g, feeding temperature: 25 ± 2 ℃, humidity: 40-70%, 12h light and shade alternate illumination, and free intake and drinking. All experiments were approved and approved by the laboratory animal ethics committee and performed according to the operating guidelines.
After 7 days of adaptive feeding, the rats are divided into a blank group and a hyperglycemic group after fasting for 16 hours without water prohibition, and are injected with 2% alloxan solution in the abdominal cavity, the first intraperitoneal injection dosage is 150mg/kg of 2% alloxan solution, and the second intraperitoneal injection dosage is 120mg/kg of 2% alloxan solution. And 25% glucose was administered 10mL/kg after injection and gavage, respectively. Blood was collected 7 days after injection, and the blood glucose concentration was selected as the success of the diabetic rat model, and the same amount of physiological saline was injected daily to the rats in the blank group.
48 experimental mice in a hyperglycemia group which are successfully modeled are randomly selected, are randomly divided into 6 groups and are respectively numbered as an experiment I group, an experiment II group, an experiment III group, an experiment IV group, an experiment V group and a control II group, 8 experimental mice in each group are repeated. From the blank group, 8 mice were randomly selected as control group I mice, one replicate for each mouse.
The 5 plant source nutrition powders prepared in the example 1 are used as reference products, each group of reference products (powder) are weighed according to the dosage of 105mg/kg, the reference products are mixed with boiled water to prepare feeding liquid, the feeding liquid is used for feeding experimental mice of an experimental group, and the experimental mice of a control group I and a control group II are fed with normal saline. Groups of mice and corresponding gavage liquid are shown in table 1.
2. Data acquisition mode
Blood was collected on days 0, 7 and 14 after feeding the test products to measure fasting blood glucose, rats in each group were fasted without water supply during the blood collection day, and blood was collected by tail-cutting method and blood glucose value was measured by glucometer according to the instruction.
3. Results of the experiment
The fasting blood glucose test results of the experimental mice are shown in table 4, and before the test products are fed, the blood glucose values of the experimental mice in the experimental groups I-V and the experimental mice in the control group II are obviously higher than those of the control group I, so that the successful modeling of the experimental mice in the experimental groups I-V and the hyperglycemic experimental mice in the control group II is shown. After the feeding experiment is carried out, the blood sugar values of the experimental rats of the experimental IV group and the experimental V group are obviously reduced on the 7 th day, the blood sugar values of the experimental rats of the experimental I-V groups are reduced to a certain extent on the 14 th day, and the blood sugar values of the experimental rats of the experimental IV group and the experimental V group are close to the normal blood sugar level.
TABLE 4 fasting blood glucose test results (unit: mmol/L) of the experimental mouse of this example
Group of | |
|
|
Control group I | 5.4 | 5.5 | 5.4 |
Control group II | 25.6 | 25.8 | 26.4 |
Experiment I group | 25.9 | 19.8 | 8.4 |
Experiment II group | 26.1 | 22.8 | 13.3 |
Experiment group III | 25.8 | 20.7 | 9.3 |
Experimental group IV | 25.9 | 18.4 | 6.9 |
Experiment group V | 26.0 | 17.2 | 5.6 |
According to the experimental results of this example, 5 plant-derived nutrition powders prepared in example 1 can effectively reduce the blood sugar level of laboratory mice, and the order of the blood sugar reducing effect is as follows: the plant source nutrition powder E, the plant source nutrition powder D, the plant source nutrition powder A, the plant source nutrition powder C and the plant source nutrition powder B are sequentially mixed.
Although the present invention has been described in detail with reference to the preferred embodiments, it will be understood by those skilled in the art that various changes, modifications, and equivalents may be made therein without departing from the spirit and scope of the invention.
Claims (8)
1. The plant source nutrition powder is characterized by comprising the following raw materials in parts by weight: 3-10 parts of soybeans, 3-8 parts of Chinese yam, 2-7 parts of saussurea involucrate seeds, 8-15 parts of oats, 5-10 parts of almonds, 0-1.5 parts of white sesame seeds, 0-1.5 parts of walnuts, 0-20 parts of coix seeds, 0-20 parts of poria cocos and 50-80 parts of coconut powder.
2. The plant nutrition powder as claimed in claim 1, wherein the raw materials comprise, in parts by mass: 3.5-6 parts of soybeans, 4-7 parts of Chinese yam, 2.5-5 parts of saussurea involucrate seeds, 10-15 parts of oats, 6-9 parts of almonds, 1-8 parts of coix seeds, 1-5 parts of poria cocos and 60-70 parts of coconut powder.
3. The plant source nutrition powder of claim 1, wherein the raw materials comprise, in parts by mass: 5 parts of soybeans, 5 parts of Chinese yam, 4 parts of snow lotus seeds, 12 parts of oats, 8 parts of almonds, 1 part of white sesames, 1 part of walnuts, 3 parts of coix seeds, 2 parts of poria cocos and 64 parts of coconut powder.
4. The plant-derived nutritional powder of claim 1, wherein: the raw materials also comprise 0.5-3 parts of trehalose by weight.
5. The plant-derived nutritional powder of claim 4, wherein: the raw materials comprise 1 part of trehalose by weight.
6. A method of producing a plant derived nutritional powder according to any one of claims 1 to 5, comprising the steps of, in order:
steam explosion pretreatment: performing steam explosion pretreatment on the raw materials by adopting a steam explosion method to obtain a steam explosion product;
and (3) drying: drying the steam explosion product;
a material mixing step: and uniformly mixing the dried materials to obtain a finished product.
7. The preparation method of the plant source nutrition powder as claimed in claim 6, wherein the specific parameters of the steam explosion pretreatment step are as follows: setting the steam explosion pressure at 0.5-3 MPa, and maintaining for 15-45 s.
8. A method for eating the plant source nutrition powder as claimed in any one of claims 1 to 5, which is characterized in that: according to the plant source nutrition powder: milk 1: 3-10, and the plant source nutrition powder is added into milk for administration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010029153.4A CN111227229A (en) | 2020-01-13 | 2020-01-13 | Plant source nutrition powder and preparation method and edible method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010029153.4A CN111227229A (en) | 2020-01-13 | 2020-01-13 | Plant source nutrition powder and preparation method and edible method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111227229A true CN111227229A (en) | 2020-06-05 |
Family
ID=70862069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010029153.4A Pending CN111227229A (en) | 2020-01-13 | 2020-01-13 | Plant source nutrition powder and preparation method and edible method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111227229A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114698831A (en) * | 2022-04-28 | 2022-07-05 | 贵州省现代农业发展研究所(贵州省现代农村发展研究中心、贵州省农村经济与社会发展科学研究所、贵州省农产品加工研究所) | Instant bamboo fungus flavor nutrition powder for reducing cholesterol and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1408264A (en) * | 2002-09-17 | 2003-04-09 | 刘洪涛 | Multiple element nutritive powder |
CN102726536A (en) * | 2011-04-11 | 2012-10-17 | 成佩秀 | Heat-releasing and dampness-eliminating soya-bean milk and preparation method thereof |
CN105124381A (en) * | 2015-08-26 | 2015-12-09 | 中国农业科学院农产品加工研究所 | Compound brown rice nutrition food and production method thereof |
CN106942731A (en) * | 2017-02-24 | 2017-07-14 | 今磨房(北京)健康科技有限公司 | A kind of nutrient powder eaten suitable for the three high patients and preparation method thereof |
CN106974288A (en) * | 2017-05-09 | 2017-07-25 | 张新成 | It is adapted to nutrient powder of patients with diabetes mellitus and preparation method thereof |
CN108041457A (en) * | 2017-12-05 | 2018-05-18 | 四川金岁方药业有限公司 | A kind of tuckahoe nutrient powder and preparation method thereof |
CN108685014A (en) * | 2018-04-28 | 2018-10-23 | 安徽工程大学 | A kind of preparation method of Job's tears powder |
CN110025013A (en) * | 2019-05-24 | 2019-07-19 | 巢湖市营养学会 | A kind of selenium-rich nutritive meal replacement powder |
-
2020
- 2020-01-13 CN CN202010029153.4A patent/CN111227229A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1408264A (en) * | 2002-09-17 | 2003-04-09 | 刘洪涛 | Multiple element nutritive powder |
CN102726536A (en) * | 2011-04-11 | 2012-10-17 | 成佩秀 | Heat-releasing and dampness-eliminating soya-bean milk and preparation method thereof |
CN105124381A (en) * | 2015-08-26 | 2015-12-09 | 中国农业科学院农产品加工研究所 | Compound brown rice nutrition food and production method thereof |
CN106942731A (en) * | 2017-02-24 | 2017-07-14 | 今磨房(北京)健康科技有限公司 | A kind of nutrient powder eaten suitable for the three high patients and preparation method thereof |
CN106974288A (en) * | 2017-05-09 | 2017-07-25 | 张新成 | It is adapted to nutrient powder of patients with diabetes mellitus and preparation method thereof |
CN108041457A (en) * | 2017-12-05 | 2018-05-18 | 四川金岁方药业有限公司 | A kind of tuckahoe nutrient powder and preparation method thereof |
CN108685014A (en) * | 2018-04-28 | 2018-10-23 | 安徽工程大学 | A kind of preparation method of Job's tears powder |
CN110025013A (en) * | 2019-05-24 | 2019-07-19 | 巢湖市营养学会 | A kind of selenium-rich nutritive meal replacement powder |
Non-Patent Citations (4)
Title |
---|
周瑞等: "《心血管病食疗》", 31 August 2015, 第二军医大学出版社 * |
徐上德: "《十谷米养生健康法》", 31 July 2009, 京华出版社 * |
煙圈圈: "茯苓,薏米,黑芝麻,山药,杏仁,黄豆,燕麦,这些混合打成粉泡水来喝有什么作用吗", 《搜狗问问》 * |
项金明: "《对症食材养生家常菜》", 31 May 2017, 辽宁科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114698831A (en) * | 2022-04-28 | 2022-07-05 | 贵州省现代农业发展研究所(贵州省现代农村发展研究中心、贵州省农村经济与社会发展科学研究所、贵州省农产品加工研究所) | Instant bamboo fungus flavor nutrition powder for reducing cholesterol and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102524659A (en) | Grain formula with nutrition and health care functions | |
CN101023802A (en) | Series products of all-nutrient green health-care bean vermicellic and instant bean vermicellic and preparing method | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN109757641A (en) | A kind of ginseng small-molecular peptides beverage and preparation method thereof | |
CN104207150A (en) | Oral liquid containing soybean peptides and fungi polysaccharides and preparation method thereof | |
CN106036420A (en) | Tartary buckwheat health care food applicable to diabetics and preparation method thereof | |
CN108294231A (en) | It is suitble to the nutritional staple food of patients with diabetes mellitus | |
CN108477609A (en) | A kind of burdock weight losing meal-replacing stick and preparation method thereof | |
US20080124416A1 (en) | Therapeutic composition from goji (lycium barbarum l.), methods of making and using | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
CN107890117A (en) | A kind of compound oligomeric peptide nutrient powder of WPC | |
CN109939143A (en) | A kind of Chinese medicine composition and preparation method thereof for hypoglycemic control complication | |
CN1742927A (en) | Medicinal tablet made from fruit of Chinese wolfberry and spica Mori and its preparing process | |
CN106307252A (en) | Quickly brewed instant purple sweet potato paste and preparation method thereof | |
CN109170916A (en) | One kind keeps fit and healthy food compositions and preparation method thereof | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
CN105380073A (en) | Instant nutritious food for diabetes | |
CN111227229A (en) | Plant source nutrition powder and preparation method and edible method thereof | |
CN108782679A (en) | A kind of weight-reducing intervention is dry and preparation method thereof for refreshment | |
KR20160141027A (en) | Phamaceutical composition or healthy food comprising water extracts from Pleurotus eryngii var. ferulea (Pf.). for treating or preventing metabolic disorder | |
CN108576827A (en) | Peri-operation period nutraceutical | |
CN104509791A (en) | Enriched rice suitable for triple-high people and preparation method for enriched rice | |
CN107095300A (en) | A kind of biological nutrition compound composition of auxiliary treatment diabetes | |
CN106805252A (en) | A kind of fish small peptide and its application in nutrition fortifier |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200605 |
|
RJ01 | Rejection of invention patent application after publication |